"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
Part of paid clinical trials in San Francisco, California.
- Sponsor
- University of California, San Francisco
- Study ID
- NCT07222618
- Status
- Recruiting
Conditions
- MS
- MS (Multiple Sclerosis)
- Multiple Sclerosis
- Multiple Sclerosis (MS) - Relapsing-remitting
- Multiple Sclerosis (MS) Primary Progressive
- Multiple Sclerosis (MS) Secondary Progressive
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The goal of this observational study is to validate a novel, cost-effective method for real-world assessment using patient-acquired "selfie" videos in people with multiple sclerosis. The investigators aim to prove the feasibility and validity of monitoring walking changes remotely through a truly patient-centered, low-burden, low-cost approach. The main question this study aims to answer is: do remotely collected walking and speech videos from a mobile phone match the information investigators can gather from an in person visit? Participants will collect 5 "selfie" videos at baseline, 3 months, 6 months and 12 months (about 15 minutes every 3 months). They will also come in person at baseline, 6 months, and 12 months for in person data collection (about 1 hour per in person visit).
Key Dates
- Start date
- Oct 1, 2025
- Status verified
- Oct 2025
- Primary completion
- Oct 1, 2028
- Completion
- Oct 1, 2028
Study Design
- Enrollment
- 300 participants (estimated)
Primary Outcome Measure
Validate key metrics derived from video "selfies" against the MS Functional Composite (MSFC) [ Time Frame: 1 year ]
Central Contacts
- Kyra Henderson, Study Coordinator415-353-8053
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California, San Francisco | San Francisco | California | 94158 | Riley Bove, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in San Francisco, CA
Related Studies
- Serum Auto-Antibodies in Neurological DiseasesEnrolling By Invitation · University of California, Davis · Sacramento, California
- ECoG BMI for Motor and Speech ControlRecruiting · Karunesh Ganguly · San Francisco, California
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Entire-body PET Scans for Multiple SclerosisEARLY_PHASE1 · Recruiting · Brain Health Alliance · Ladera Ranch, California